# Takeda Pharmaceuticals USA, Inc., Deerfield, IL – FDA Inspections

Source: https://www.keypedia.com/companies/takeda-pharmaceuticals-usa-inc/678d8802-0216-41d5-bdd6-38999c144876

> Inspection records and compliance data for Takeda Pharmaceuticals USA, Inc. in Deerfield, Illinois. 6 FDA inspections on record, last inspected October 25, 2019.

---

## Details

- Name: Takeda Pharmaceuticals USA, Inc.
- FEI Number: 3002393210
- Address Line 1: 1 Takeda Pkwy
- City: Deerfield
- State: Illinois
- Zip Code: 60015
- Country Name: United States
- Address: 1 Takeda Pkwy, Deerfield, Illinois 60015, United States
- Country: United States

## Related Documents

- [483 - Takeda Pharmaceuticals USA, Inc. - Unknown Date](https://www.keypedia.com/records/483/takeda-pharmaceuticals-usa-inc/da485ef1-26ca-4a32-9311-d2bcb54158ac) — source: FDA, date: Invalid Date
- FDA Inspection 1107731 - Takeda Pharmaceuticals USA, Inc. - 2019-10-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2019
- [483 - Takeda Pharmaceuticals USA, Inc. - 2016-09-09](https://www.keypedia.com/records/483/takeda-pharmaceuticals-usa-inc/5be6121b-721f-41ef-baf1-a0f0a4712881) — source: FDA, date: September 9, 2016
- [FDA Inspection 988237 - Takeda Pharmaceuticals USA, Inc. - 2016-09-09](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa-inc/79ce5fb5-95a6-43f1-b5a1-8073b2a5b82a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 9, 2016
- FDA Inspection 818340 - Takeda Pharmaceuticals USA, Inc. - 2013-01-28 — classification: No Action Indicated (NAI), source: FDA, date: January 28, 2013
- FDA Inspection 811093 - Takeda Pharmaceuticals USA, Inc. - 2013-01-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 18, 2013
- [FDA Inspection 811093 - Takeda Pharmaceuticals USA, Inc. - 2013-01-18](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa-inc/9a2e2493-95a8-4426-a28d-f249cb9a6c6d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 18, 2013
- FDA Inspection 756349 - Takeda Pharmaceuticals USA, Inc. - 2011-12-08 — classification: No Action Indicated (NAI), source: FDA, date: December 8, 2011
- FDA Inspection 662088 - Takeda Pharmaceuticals USA, Inc. - 2010-04-27 — classification: No Action Indicated (NAI), source: FDA, date: April 27, 2010

## Related Companies

- [Sunandana Chandra, M.D.](https://www.keypedia.com/companies/sunandana-chandra-md/a091d168-e82f-4647-bf29-22c91ba6fc32)
- [Teva Branded Pharmaceutical Products R&D](https://www.keypedia.com/companies/teva-branded-pharmaceutical-products-rd/7e833f16-5791-422a-944a-bf999e8b8885)
- [Caribe Holdings (Cayman) Co. Ltd dba PuraCap Caribe](https://www.keypedia.com/companies/caribe-holdings-cayman-co-ltd-dba-puracap-caribe/e746116a-a57b-4872-a647-5ea6d497ff3e)
- [Omega Tech Labs, LLC](https://www.keypedia.com/companies/omega-tech-labs-llc/85cf5888-6344-4179-9b59-4610833d6f11)
- [Sant P. Chawla, MD](https://www.keypedia.com/companies/sant-p-chawla-md/12b13bee-4e0f-4d72-a3a7-217e48fb68ef)
- [Donald J Garcia, Jr. M.D.](https://www.keypedia.com/companies/donald-j-garcia-jr-md/a9185c7c-8af7-4f76-83f6-d313765a3dae)
- [Corcept Therapeutics Incorporated](https://www.keypedia.com/companies/corcept-therapeutics-incorporated/9f3284cd-b285-4408-818e-19b78043d2e3)
- [GlaxoSmithKline LLC](https://www.keypedia.com/companies/glaxosmithkline-llc/3e32166b-cf0c-496b-b725-b1687e48a928)
- [Nesher Pharmaceuticals (USA) LLC](https://www.keypedia.com/companies/nesher-pharmaceuticals-usa-llc/5198bc9c-156b-4adf-ab9d-7ca6271a62bb)
- [Syneos Health](https://www.keypedia.com/companies/syneos-health/a2842cea-ef97-4a3d-92be-6af32c00ccaf)

## Related Officers

- [Bryan L. Mcguckin](https://www.keypedia.com/people/bryan-l-mcguckin/33eaa16d-a642-4945-81f3-5d9ac180c2db)
- [issuing_officer](https://www.keypedia.com/people/jennifer-c-adams/85608566-bd13-41d8-b86e-cc9111c7dfe5)